Sang Ju Yin and SARS
Traditional Chinese medicine (TCM) has been used for
prevention and treatment of severe acute respiratory syndrome (SARS) in Hong
Kong during the outbreak in spring 2003. We investigated the immunomodulating
effects of an innovative TCM regimen derived from two herbal formulas (Sang Ju
Yin and Yu Ping Feng San) for treating febrile diseases. Thirty-seven healthy
volunteers were given the oral TCM regimen daily for 14 days. Peripheral venous
blood samples were taken on days 0, 15 and 29 for hematology, biochemistry and
immunology tests, including the measurement of blood lymphocyte subsets and
plasma T-helper lymphocyte types 1 and 2 cytokines and receptor. After 3
months, 23 of the volunteers participated in a control study without TCM
treatment for the same time course of blood tests. Two volunteers withdrew on
day 2, due to headache and dizziness. All others remained well without any side
effects. No participants showed significant changes in their blood test
results, except that the T-lymphocyte CD4/CD8 ratio increased significantly
from 1.31 +/- 0.50 (mean +/- SD) on day 0 to 1.41 +/- 0.63 on day 15 (p <
0.02), and reduced to 1.32 +/- 0.47 on day 29 (p < 0.05). In the control
study, there were no changes in the CD4/CD8 ratio. The transient increase in
CD4/CD8 ratio was likely due to the TCM intake. We postulate that the
administration of the innovative TCM may have beneficial immunomodulatory
effects for preventing viral infections including SARS.
No comments:
Post a Comment